Health Condition 1: null- Patients suffering from Hemiplegia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 2. SEX: Both male and female. 3. Inability/ difficulty to use one side of the upper and lower limb. 4. Difficulty in speech. 5. Patient with Thrombotic or Embolic stroke. 6. Willing for admission in IPD for 48 days or willing to attend OPD regularly. 7. Patients who are willing to participate in this study with knowledge of potential risks and who are willing to sign the informed consent form. 8. Patient who are willing to give blood sample for laboratory investigation
Exclusion criteria
Exclusion criteria: 1. Patient in an acute phase of CVA. 2. Pregnant women and lactating mother. 3. Known Hypersensitivity or allergy to trial drugs. 4. Patients with other serious, advanced or terminal illness. 5. Bed sores. 6. Bladder and Bowel control lost. 7. Epilepsy. 8. Comatose and unconscious patients. 9. Patient with haemorrhagic stroke, Neoplasam, subarachanoid haemorrhage, AV malformation. 10. Dermatological issues. 11. Congenital defects -diffuse sclerosis, cerebral agenesis etc. 12. Post operative cases within 3 months [eg.CVD, etc.], Head injury.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be assessed based on assessment criteria for stroke patientsTimepoint: 48 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of quality of life with respect to SS-QOL. 2.Assessment of improvement in clinical signs and symptoms with respect to following of Iyama and Niyama. 3.To evaluate the clinical efficacy of the trial drug with respect to theganilai. Timepoint: 48 days | — |
Countries
India
Contacts
Govt Siddha Medical College Hospital